← All indications
Breast Diseases
Pathological processes of the BREAST.
Subtype terms (6)
More specific conditions that are subtypes of Breast Diseases in the MeSH hierarchy.
- Breast Cyst
- Breast Neoplasms
2017 drugs (591 approved, 1426 experimental)
- Fibrocystic Breast Disease
10 drugs (5 approved, 5 experimental)
- Gynecomastia
3 drugs approved
- Lactation Disorders
18 drugs (11 approved, 7 experimental)
- Mastitis
13 drugs (7 approved, 6 experimental)
Drugs by status
Approved for this indication (1)
Phase 4 trials (15)
Phase 3 trials (20)
Phase 2 trials (24)
Phase 1 trials (6)
Organizations
Organization Involved with Phase 4 Indications (8)
Organization Involved with Phase 3 Indications (10)
Organization Involved with Phase 2 Indications (22)
- Incyte
- Novartis
- FemmePharma Global Healthcare, Inc.
- GlaxoSmithKline
- RemeGen
- PharmaMar
- National Cancer Institute (NCI)
- Instituto Nacional de Cancer, Brazil
- Baylor University
- Cornell University
- Faculdade de Medicina do ABC
- Herbert Irving Comprehensive Cancer Center
- New York University
- University of Maryland
- Icahn School of Medicine at Mount Sinai
- Sun Yat-Sen University
- University of Texas at Houston
- Hospital do Cancer III - INCA
- Government of Brazil
- Sungkyunkwan University
- Johnson and Johnson
- People's Liberation Army of China
Organization Involved with Phase 1 Indications (5)
Organization Involved with Other Experimental Indications (5)